Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

The Efficacy and Safety of Clonidine Hydrochloride Topical Gel, vs Clonidine Hydrochloride Gel Comparator to Treat Painful Diabetic Neuropathy

ClinicalTrials.gov ID: NCT02643251

Public ClinicalTrials.gov record NCT02643251. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 1:20 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Randomized, Double Blind, Parallel-Group Study Comparing the Efficacy and Safety of Clonidine Hydrochloride Topical Gel, 0.1%, to Clonidine Hydrochloride Gel Comparator in the Management of Painful Diabetic Neuropathy

Study identification

NCT ID
NCT02643251
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
BioDelivery Sciences International
Industry
Enrollment
138 participants

Conditions and interventions

Interventions

  • Clonidine Hydrochloride Topical Gel, 0.1% Drug
  • Clonidine Hydrochloride Gel Comparator Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 30, 2015
Primary completion
Oct 31, 2016
Completion
Oct 31, 2016
Last update posted
Sep 19, 2017

2015 – 2016

United States locations

U.S. sites
25
U.S. states
10
U.S. cities
23
Facility City State ZIP Site status
Not listed Glendale Arizona 85308
Not listed Phoenix Arizona 85018
Not listed Phoenix Arizona 85023
Not listed Anaheim California 92801
Not listed Norco California 92860
Not listed Sacramento California 95821
Not listed Santa Monica California 90404
Not listed Tustin California 92780
Not listed Fort Myers Florida 33912
Not listed Ocala Florida 34471
Not listed Orlando Florida 32801
Not listed Tampa Florida 33634
Not listed West Palm Beach Florida 33401
Not listed Blackfoot Idaho 83321
Not listed Boise Idaho 83642
Not listed Belleville Illinois 62220
Not listed Blue Island Illinois 60406
Not listed Chicago Illinois 60616
Not listed Hazelwood Missouri 63042
Not listed Cleveland Ohio 44122
Not listed Spartanburg South Carolina 29303
Not listed Knoxville Tennessee 37909
Not listed Houston Texas 77030
Not listed San Antonio Texas 78218
Not listed San Antonio Texas 78228

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02643251, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 19, 2017 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02643251 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →